These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 16141329)

  • 21. Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides.
    Betser-Cohen G; Katz G; Gonen-Gross T; Stern N; Arnon TI; Achdout H; Gazit R; Mandelboim O
    J Immunol; 2006 Jun; 176(11):6762-9. PubMed ID: 16709835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
    Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
    Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
    Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
    J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
    Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands.
    Ma BJ; Craveiro Salvado CM; Kane KP
    Immunogenetics; 2014 Aug; 66(7-8):467-77. PubMed ID: 24797174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.
    Fauriat C; Ivarsson MA; Ljunggren HG; Malmberg KJ; Michaëlsson J
    Blood; 2010 Feb; 115(6):1166-74. PubMed ID: 19903900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced recognition of human NK receptors after influenza virus infection.
    Achdout H; Arnon TI; Markel G; Gonen-Gross T; Katz G; Lieberman N; Gazit R; Joseph A; Kedar E; Mandelboim O
    J Immunol; 2003 Jul; 171(2):915-23. PubMed ID: 12847262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.
    Chewning JH; Gudme CN; Hsu KC; Selvakumar A; Dupont B
    J Immunol; 2007 Jul; 179(2):854-68. PubMed ID: 17617576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
    Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
    Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.
    Naumova E; Mihaylova A; Ivanova M; Mihailova S
    Cancer Immunol Immunother; 2007 Jan; 56(1):95-100. PubMed ID: 16547704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705.
    Peruzzi M; Wagtmann N; Long EO
    J Exp Med; 1996 Oct; 184(4):1585-90. PubMed ID: 8879234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Killer immunoglobulin-like receptors.
    Moretta L; Moretta A
    Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular cysteine residues in the tail of MHC class I proteins are crucial for extracellular recognition by leukocyte Ig-like receptor 1.
    Gruda R; Achdout H; Stern-Ginossar N; Gazit R; Betser-Cohen G; Manaster I; Katz G; Gonen-Gross T; Tirosh B; Mandelboim O
    J Immunol; 2007 Sep; 179(6):3655-61. PubMed ID: 17785801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin-like receptor multigene family contains members with divergent signaling motifs.
    Storset AK; Slettedal IO; Williams JL; Law A; Dissen E
    Eur J Immunol; 2003 Apr; 33(4):980-90. PubMed ID: 12672064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenetics of killer cell immunoglobulin-like receptors.
    Parham P
    Mol Immunol; 2005 Feb; 42(4):459-62. PubMed ID: 15607799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide-specific engagement of the activating NK cell receptor KIR2DS1.
    Chapel A; Garcia-Beltran WF; Hölzemer A; Ziegler M; Lunemann S; Martrus G; Altfeld M
    Sci Rep; 2017 May; 7(1):2414. PubMed ID: 28546555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.